Abstract:Interleukin-1 (IL-1) signaling is essential for controlling virulent Mycobacterium tuberculosis ( Mtb ) infection since antagonism of this pathway leads to exacerbated pathology and increased susceptibility. In contrast, the triggering of type I interferon (IFN) signaling is associated with the progression of tuberculosis (TB) disease and linked with negative regulation of IL-1 signaling. However, mice lacking IL-1 signaling can control Mtb infection if infected with an Mtb strain carrying the rifampin-resistance conferring mutation H445Y in its RNA polymerase β subunit ( rpoB -H445Y Mtb ). The mechanisms that govern protection in the absence of IL-1 signaling during rpoB -H445Y Mtb infection are unknown. In this study, we show that in the absence of IL-1 signaling, type I IFN signaling controls rpoB -H445Y Mtb replication, lung pathology, and excessive myeloid cell infiltration. Additionally, type I IFN is produced predominantly by monocytes and recruited macrophages and acts on LysM-expressing cells to drive protection through nitric oxide (NO) production to restrict intracellular rpoB -H445Y Mtb . These findings reveal an unexpected protective role for type I IFN signaling in compensating for deficiencies in IL-1 pathways during rpoB -H445Y Mtb infection. Mycobacterium tuberculosis ( Mtb ) is the causative agent of tuberculosis (TB) and is responsible for 10 million active cases worldwide annually. The acquisition and dissemination of drug resistance to front-line antibiotics have stifled efforts to control and combat TB. Understanding the immune responses elicited during Mtb infection is imperative to develop novel therapeutics that bolster protective responses and limit detrimental processes. Recently, we found that mice do not require the inflammatory interleukin-1 (IL-1) signaling pathway to control Mtb infection if the infecting bacterial strains carry a specific drug resistance-conferring mutation. Instead, here we show that a different signaling pathway, type I interferon (IFN), mediates protection against drug-resistant mutant Mtb infection in the absence of IL-1 signaling. We also found that the primary producers of type I IFN during drug-resistant Mtb infection were recruited innate cells, namely monocytes and macrophages. The downstream impacts of IFN signals were varied, with macrophages restricting bacterial replication while other immune cell functions were likely impaired by IFN signaling. Our study provides new insights into the different host requirements for protection against infection by various Mtb strains and highlights the unexpected roles for type I IFN signaling during Mtb infection.

IL-1R1-Dependent Signals Improve Control of Cytosolic Virulent Mycobacteria In Vivo

ROLE OF TOLL-LIKE RECEPTORS SENSING AND CONTROL OFMYCOBACTERIAL INFECTION

IL-1 Receptor-Mediated Signal is an Essential Component of MyD88-dependent Innate Response to Mycobacterium Tuberculosis Infection.

Interleukin-1 receptor antagonist is a conserved driver of tuberculosis

Mycobacterium tuberculosis hijacks host macrophages-derived interleukin 16 to block phagolysosome maturation for enhancing intracellular growth

Relative Contribution of IL-1α, IL-1β and TNF to the Host Response to Mycobacterium Tuberculosis and Attenuated M. Bovis BCG.

Limited Contribution of IL-36 Versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection

A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y

Innate Myeloid Cell Tnfr1 Mediates First Line Defence Against Primary Mycobacterium Tuberculosis Infection

Mycobacterium tuberculosis Induces Irg1 in Murine Macrophages by a Pathway Involving Both TLR-2 and STING/IFNAR Signaling and Requiring Bacterial Phagocytosis

Mycobacterium Tuberculosis Rv3402c Enhances Mycobacterial Survival Within Macrophages and Modulates the Host Pro-Inflammatory Cytokines Production Via NF-kappa B/ERK/p38 Signaling.

Rv3369 Induces Cytokine Interleukin-1β Production and EnhancesMycobacterium Smegmatisintracellular Survival

Interleukin-1 receptor antagonist mediates type I interferon-driven susceptibility to Mycobacterium tuberculosis

Partial Redundancy of the Pattern Recognition Receptors, Scavenger Receptors, and C-Type Lectins for the Long-Term Control of<i>Mycobacterium</i><i>tuberculosis</i>Infection

Prominent Role for T Cell-Derived Tumour Necrosis Factor for Sustained Control of Mycobacterium Tuberculosis Infection

Partial Redundancy of the Pattern Recognition Receptors, Scavenger Receptors, and C-Type Lectins for the Long-Term Control of Mycobacterium Tuberculosis Infection

Tumor Necrosis Factor and Its Receptors Are Crucial to Control Mycobacterium Bovis Bacillus Calmette-Guerin Pleural Infection in a Murine Model

Allele-specific Induction of IL-1β Expression by C/EBPβ and PU.1 Contributes to Increased Tuberculosis Susceptibility.

MicroRNA 26a (miR-26a)/KLF4 and CREB-C/EBPβ regulate innate immune signaling, the polarization of macrophages and the trafficking of Mycobacterium tuberculosis to lysosomes during infection

NF-κB signaling deficiency in CD11c-expressing phagocytes mediates early inflammatory responses and enhances Mycobacterium tuberculosis control

Deficiency of the AIM2–ASC Signal Uncovers the STING-Driven Overreactive Response of Type I IFN and Reciprocal Depression of Protective IFN-γ Immunity in Mycobacterial Infection